Literature DB >> 25752398

Pelvic nodal dosing with registration to the prostate: implications for high-risk prostate cancer patients receiving stereotactic body radiation therapy.

Amar U Kishan1, James M Lamb2, Shyam S Jani2, Jung J Kang2, Michael L Steinberg2, Christopher R King2.   

Abstract

PURPOSE: To determine whether image guidance with rigid registration (RR) to intraprostatic markers (IPMs) yields acceptable coverage of the pelvic lymph nodes in the context of a stereotactic body radiation therapy (SBRT) regimen. METHODS AND MATERIALS: Four to seven kilovoltage cone-beam CTs (CBCTs) from 12 patients with high-risk prostate cancer were analyzed, allowing approximation of an SBRT regimen. The nodal clinical target volume (CTV(N)) and bladder were contoured on all kilovoltage CBCTs. The V100 CTV(N), expressed as a ratio to the same parameter on the initial plan, and the magnitude of translational shift between RR to the IPMs versus RR to the pelvic bones, were computed. The ability of a multimodality bladder filling protocol to minimize bladder height variation was assessed in a separate cohort of 4 patients.
RESULTS: Sixty-five CBCTs were assessed. The average V100 CTV(N) was 92.6%, but for a subset of 3 patients the average was 80.0%, compared with 97.8% for the others (P<.0001). The average overall and superior-inferior axis magnitudes of the bony-to-fiducial translations were significantly larger in the subgroup with suboptimal nodal coverage (8.1 vs 3.9 mm and 5.8 vs 2.4 mm, respectively; P<.0001). Relative bladder height changes were also significantly larger in the subgroup with suboptimal nodal coverage (42.9% vs 18.5%; P<.05). Use of a multimodality bladder-filling protocol minimized bladder height variation (P<.001).
CONCLUSION: A majority of patients had acceptable nodal coverage after RR to IPMs, even when approximating SBRT. However, a subset of patients had suboptimal nodal coverage. These patients had large bony-to-fiducial translations and large variations in bladder height. Nodal coverage should be excellent if the superior-inferior axis bony-to-fiducial translation and the relative bladder height change (both easily measured on CBCT) are kept to a minimum. Implementation of a strict bladder filling protocol may achieve this goal.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25752398     DOI: 10.1016/j.ijrobp.2014.11.035

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  Stereotactic body radiotherapy to the prostate and pelvic lymph nodes: A detailed dosimetric analysis of a phase II prospective trial.

Authors:  Amar U Kishan; Marguerite Tyran; Julius Weng; Shrinivasa Upadhyaya; James Lamb; Michael Steinberg; Christopher King; Minsong Cao
Journal:  Br J Radiol       Date:  2019-04-03       Impact factor: 3.039

Review 2.  Image-guided radiotherapy for prostate cancer.

Authors:  Audrey Dang; Patrick A Kupelian; Minsong Cao; Nzhde Agazaryan; Amar U Kishan
Journal:  Transl Androl Urol       Date:  2018-06

Review 3.  MR-Guided Radiotherapy for Prostate Cancer.

Authors:  Boris R Tocco; Amar U Kishan; Ting Martin Ma; Linda G W Kerkmeijer; Alison C Tree
Journal:  Front Oncol       Date:  2020-12-09       Impact factor: 6.244

4.  Impact of rotational errors of whole pelvis on the dose of prostate-based image-guided radiotherapy to pelvic lymph nodes and small bowel in high-risk prostate cancer.

Authors:  Hiroki Katayama; Shigeo Takahashi; Takuya Kobata; Akihiro Oishi; Toru Shibata
Journal:  Rep Pract Oncol Radiother       Date:  2021-12-30

5.  Prostate-Centric Versus Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer with Simultaneous Integrated Boost: A Dosimetric Comparison.

Authors:  Trudy C Wu; Michael Xiang; Nicholas G Nickols; Stephen Tenn; Nzhde Agazaryan; John V Hegde; Michael L Steinberg; Minsong Cao; Amar U Kishan
Journal:  Adv Radiat Oncol       Date:  2022-03-16

6.  A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy.

Authors:  Ciara A Lyons; Raymond B King; Sarah O S Osman; Stephen J McMahon; Joe M O'Sullivan; Alan R Hounsell; Suneil Jain; Conor K McGarry
Journal:  Radiat Oncol       Date:  2017-08-04       Impact factor: 3.481

7.  Inter-fraction movements of the prostate and pelvic lymph nodes during IGRT.

Authors:  Ulrika Björeland; Joakim Jonsson; Magnus Alm; Lars Beckman; Tufve Nyholm; Camilla Thellenberg-Karlsson
Journal:  J Radiat Oncol       Date:  2018-11-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.